PL
MEDP icon

Polianta Ltd’s Medpace MEDP Stock Holding History

Polianta Ltd’s Portfolio MEDP Stock Details MEDP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.8M Buy
3,400
+600
+21% +$277K 0.22% 51
2026
Q1 		$1.34M Hold
2,800
– – 0.18% 74
2025
Q4 		$1.57M Buy
+2,800
New +$1.59M 0.21% 30
2020
Q4 		– Sell
-9,500
Closed -$1.06M – 82
2020
Q3 		$1.06M Buy
+9,500
New +$1.1M 0.63% 61
2020
Q2 		– Sell
-10,800
Closed -$792K – 89
2020
Q1 		$792K Buy
+10,800
New +$938K 0.54% 42

Other funds holding MEDP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Polianta Ltd's MEDP Position: Q2 2026 in Review

Polianta Ltd increased its Medpace (MEDP) stake by 21% in Q2 2026, buying an estimated $277K and bringing the position to 3,400 shares worth $1.8M. The position accounts for 0.22% of the portfolio, ranked #51.

Polianta Ltd first reported a position in MEDP in Q1 2020 and has held it in 5 quarters since. 698 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.

  • Polianta Ltd held 3,400 shares of Medpace worth $1.8M as of Q2 2026.
  • Polianta Ltd bought 600 Medpace shares in Q2 2026, an estimated $277K.
  • Medpace made up 0.22% of Polianta Ltd's portfolio in Q2 2026, its #51 holding.
  • Polianta Ltd first reported a position in Medpace in Q1 2020 and has held it in 5 quarters since.
  • 698 funds tracked by Wall St. Rank held Medpace as of Q2 2026.

Based on Polianta Ltd's 13F filing for Q2 2026, filed 8 Jul 2026.